Immunovant, Inc. (IMVT)

NASDAQ: IMVT · Real-Time Price · USD

25.37

-0.57 (-2.20%)

Feb 12, 2026, 9:50 AM EST - Market open

Immunovant Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 12, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	5,164	2,903	4,694	2,005	641	1,571
Market Cap Growth	38.01%	-38.16%	134.16%	212.60%	-59.19%	84.72%
Enterprise Value	4,285	2,528	4,004	1,574	117	1,153
Last Close Price	25.94	17.09	32.31	15.51	5.51	16.04
PB Ratio	5.35	4.10	7.60	5.53	1.37	4.01
P/TBV Ratio	5.35	4.10	7.60	5.53	1.37	4.01
Debt / Equity Ratio	-	0	0	0.00	0.01	0.01
Net Debt / Equity Ratio	-1.01	-1.01	-1.03	-1.03	-1.05	-1.01
Net Debt / EBITDA Ratio	2.04	1.63	2.35	1.80	3.15	3.67
Net Debt / FCF Ratio	2.35	1.90	2.96	1.99	4.62	4.75
Quick Ratio	15.04	10.42	13.18	8.72	11.38	21.38
Current Ratio	15.74	11.16	13.70	9.34	11.52	21.79
Return on Equity (ROE)	-69.35%	-62.46%	-52.91%	-50.69%	-36.39%	-44.25%
Return on Assets (ROA)	-41.33%	-37.97%	-31.50%	-28.26%	-21.02%	-25.90%
Return on Capital Employed (ROCE)	-49.40%	-61.90%	-43.70%	-57.40%	-33.10%	-27.50%
Earnings Yield	-8.79%	-14.26%	-5.52%	-10.52%	-24.44%	-6.84%
FCF Yield	-8.01%	-12.97%	-4.57%	-9.40%	-16.59%	-5.32%
Buyback Yield / Dilution	-18.37%	-9.76%	-12.21%	-12.21%	-24.98%	-103.14%

Updated Feb 6, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q